Neuberger Berman Group
MEDP icon

Neuberger Berman Group’s Medpace MEDP Stock Holding History

Neuberger Berman Group’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.98M Buy
3,739
+169
+5% +$78K ﹤0.01% 1299
2026
Q1 		$1.71M Sell
3,570
-747
-17% -$382K ﹤0.01% 1234
2025
Q4 		$2.42M Buy
4,317
+1,020
+31% +$579K ﹤0.01% 1118
2025
Q3 		$1.7M Buy
3,297
+120
+4% +$52.4K ﹤0.01% 1194
2025
Q2 		$997K Buy
3,177
+149
+5% +$44.7K ﹤0.01% 1352
2025
Q1 		$923K Buy
3,028
+658
+28% +$221K ﹤0.01% 1348
2024
Q4 		$787K Buy
2,370
+511
+27% +$173K ﹤0.01% 1382
2024
Q3 		$621K Sell
1,859
-42
-2% -$16K ﹤0.01% 1443
2024
Q2 		$783K Buy
1,901
+46
+2% +$18.2K ﹤0.01% 1350
2024
Q1 		$750K Sell
1,855
-2,205
-54% -$775K ﹤0.01% 1367
2023
Q4 		$1.24M Buy
+4,060
New +$1.1M ﹤0.01% 1425
2023
Q2 		– Sell
-8,995
Closed -$1.69M – 1861
2023
Q1 		$1.69M Buy
8,995
+235
+3% +$48.6K ﹤0.01% 1121
2022
Q4 		$1.86M Sell
8,760
-10,710
-55% -$2.14M ﹤0.01% 1083
2022
Q3 		$3.06M Sell
19,470
-8,717
-31% -$1.39M ﹤0.01% 991
2022
Q2 		$4.22M Sell
28,187
-337
-1% -$48.8K ﹤0.01% 936
2022
Q1 		$4.67M Buy
28,524
+1,297
+5% +$214K ﹤0.01% 976
2021
Q4 		$5.78M Buy
27,227
+277
+1% +$58K ﹤0.01% 941
2021
Q3 		$5.03M Buy
26,950
+2,368
+10% +$432K ﹤0.01% 955
2021
Q2 		$4.34M Buy
+24,582
New +$4.24M ﹤0.01% 996
2019
Q1 		– Sell
-4,039
Closed -$214K – 1574
2018
Q4 		$214K Hold
4,039
– – ﹤0.01% 1478
2018
Q3 		$242K Buy
+4,039
New +$221K ﹤0.01% 1505
2018
Q1 		– Sell
-17,133
Closed -$684K – 1717
2017
Q4 		$684K Buy
+17,133
New +$601K ﹤0.01% 1326

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Neuberger Berman Group's MEDP Position: Q2 2026 in Review

Neuberger Berman Group increased its Medpace (MEDP) stake by 4.7% in Q2 2026, buying an estimated $78K and bringing the position to 3,739 shares worth $1.98M. The position accounts for ﹤0.01% of the portfolio, ranked #1299.

Neuberger Berman Group first reported a position in MEDP in Q4 2017 and has held it in 22 quarters since. The position peaked at $5.78M in Q4 2021. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Neuberger Berman Group held 3,739 shares of Medpace worth $1.98M as of Q2 2026.
  • Neuberger Berman Group bought 169 Medpace shares in Q2 2026, an estimated $78K.
  • Medpace made up ﹤0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #1299 holding.
  • Neuberger Berman Group first reported a position in Medpace in Q4 2017 and has held it in 22 quarters since.
  • Neuberger Berman Group's Medpace position peaked at $5.78M in Q4 2021.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.